FDA has acknowledged receipt of the request and assigned a pre-EUA number On May 7, 2020

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has acknowledge receipt and processing of the Emergency Use Authorization (EUA) submission for the dAb ImmunoTech COVID-19 (SARS-CoV-2) IgG and IgM Dual Antibody Test Kit.

About the dAb ImmunoTech, Inc.

dAb ImmunoTech, Inc. , a US corporation headquartered in near Atlanta, Georgia, is a Immunoassay and Immunodiagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics product and technology. dAb ImmunoTech is a provider of immuno-diagnostic and biomarker solutions designed to enhance patient care and promote health and individual well-being through cutting-edge science and technology.

For more information see: www.dabimmunotech.com